Abstract
Chronic skin diseases can substantially impact a patient's physical, psychologic,
and social well-being. Physicians may play a critical role in identifying and managing
the psychologic sequelae of the most common chronic skin conditions. Acne, atopic
dermatitis, psoriasis, vitiligo, alopecia areata, and hidradenitis suppurativa are
chronic dermatologic diseases that put patients at high risk for symptoms of depression,
anxiety, and decreased quality of life. Both general and disease-specific scales exist
to assess the quality of life in patients with chronic skin disease, the most common
being the Dermatology Life Quality Index. The general management approach to the patient
with chronic skin disease should incorporate acknowledgment and validation of the
patient's struggles, patient education on the potential impact of disease and prognosis;
medical management of the dermatologic lesions; coaching on stress management; psychotherapy.
Psychotherapies include talk therapy (i.e., cognitive behavioral therapy), arousal-reducing
therapies (i.e., meditation, relaxation), and behavioral therapies (i.e., habit reversal
therapy). Improved understanding, identification, and management of the psychiatric
and psychologic aspects of the most common chronic skin conditions by dermatologists
and other healthcare providers may positively affect patient outcomes.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinics in DermatologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Publication stage
In Press Accepted ManuscriptFootnotes
Funding Sources: None.
Conflict of Interest Disclosure: None declared.
Identification
Copyright
© 2023 Elsevier Inc. All rights reserved.